Abzena
PrivateLast Round
Private Equity
Mar 31, 2022
Est. Valuation
$44.4M
Total Funding Raised
$126.9M
Company Overview
Abzena is a biotechnology company that provides integrated discovery, development, and manufacturing services for biologics and antibody-drug conjugates (ADCs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abzena Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Abzena Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Mar 31, 2022 | ||||
| Growth Equity | Jul 28, 2020 | ||||
| Take Private | Aug 17, 2018 | ||||
| Follow-on Offering | Apr 5, 2017 | ||||
| Private Placement | Nov 24, 2015 | ||||
IPO Announced | Jul 10, 2014 |
Key People
Founding team and executive leadership
Abzena Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Invesco Ltd. | Follow-on Offering |
| Biospring Partners | Private Equity, Growth Equity |
| Cavendish | IPO |
| Woodford Investment Management | IPO, Follow-on Offering |
| Imperial Innovations | IPO, Series A |
| Invesco Perpetual | Series A, IPO |
| Welsh, Carson, Anderson & Stowe | Private Equity, Take Private |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors grew 36% MoM, reaching 15.6K.
- Oct 28, 2024
Monthly visitors increased 65% MoM.
Abzena Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abzena's valuation, stock price, and market status.